Resources Investment Advisors, Llc. Amgen Inc Transaction History

Resources Investment Advisors, Llc.

$8.43 Billion
Q3 2024

A detailed history of Resources Investment Advisors, Llc. transactions in Amgen Inc stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 18,899 shares of AMGN stock, worth $5.57 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

18,899

Previous 18,098 4.43%

Holding current value

$5.57 Million

Previous $5.65 Million 7.69%

% of portfolio

0.07%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $247,813 - $270,241	801 Added 4.43%	18,899 $6.09 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $1.08 Million - $1.32 Million	4,129 Added 29.56%	18,098 $5.65 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $91,953 - $110,999	342 Added 2.51%	13,969 $3.97 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $961,432 - $1.08 Million	-3,760 Reduced 21.63%	13,627 $3.92 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $198,315 - $246,214	-907 Reduced 4.96%	17,387 $4.67 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $156,417 - $184,960	-730 Reduced 3.84%	18,294 $4.06 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $7.36 Million - $8.98 Million	-32,613 Reduced 63.16%	19,024 $4.6 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $2.03 Million - $2.57 Million	-8,848 Reduced 14.63%	51,637 $13.6 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $283,717 - $319,981	-1,264 Reduced 2.05%	60,485 $13.6 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $225,865 - $251,348	-979 Reduced 1.56%	61,749 $15 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $704,953 - $779,862	3,215 Added 5.4%	62,728 $15.2 Million
Q4 2021 Feb 23, 2022	BUY	$198.88 - $227.6 $1.08 Million - $1.24 Million	5,445 Added 10.07%	59,513 $13.4 Million
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $682,235 - $799,321	3,214 Added 6.32%	54,068 $11.5 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $893,677 - $991,469	3,826 Added 8.14%	50,854 $12.4 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $497,078 - $579,264	2,240 Added 5.0%	47,028 $11.7 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $650,005 - $774,040	3,004 Added 7.19%	44,788 $10.3 Million
Q3 2020 Oct 09, 2020	BUY	$234.65 - $260.95 $538,287 - $598,619	2,294 Added 5.81%	41,784 $10.6 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $429,049 - $526,503	2,169 Added 5.81%	39,490 $9.31 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $691,054 - $916,526	3,792 Added 11.31%	37,321 $7.57 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $572,360 - $735,680	-3,025 Reduced 8.28%	33,529 $8.08 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $3.23 Million - $3.87 Million	-18,533 Reduced 33.64%	36,554 $7.07 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $5.11 Million - $6 Million	30,683 Added 125.73%	55,087 $0
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $119,916 - $135,172	663 Added 2.79%	24,404 $0
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $629,038 - $734,289	3,526 Added 17.44%	23,741 $4.62 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $90,606 - $102,147	489 Added 2.48%	20,215 $4.19 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $61,936 - $69,568	373 Added 1.93%	19,726 $3.56 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $741,425 - $866,448	4,376 Added 29.22%	19,353 $3.3 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $551,774 - $616,500	3,269 Added 27.92%	14,977 $2.61 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $338,093 - $386,011	-2,021 Reduced 14.72%	11,708 $2.18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	13,729	13,729 $2.37 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.

Account

Resources Investment Advisors, Llc. Amgen Inc Transaction History